SCHEMBL5822288

SCHEMBL5822288

CC(C)(C)OC(=O)NCCCCCN.CC(C)(C)[Si](C)(C)O[C@@H](CNCCCCCN)c1ccc(OCc2ccccc2)c2[nH]c(=O)ccc12

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 8/20 0.40
ADRB1 P08588 6/20 0.40
ADRB3 P13945 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.38
MAPT P10636 3/20 0.38
POLB P06746 1/20 0.37
MAPK1 P28482 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
RECQL P46063 1/20 0.36
DRD2 P14416 2/20 0.36
DRD1 P21728 2/20 0.36
DRD4 P21917 2/20 0.36
DRD3 P35462 2/20 0.36
NPSR1 Q6W5P4 2/20 0.35
PAX8 Q06710 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SYK P43405 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL963632 0.96 ADRB2 (0.42) ADRB2ADRB1ADRB3L3MBTL1MAPT
SCHEMBL963630 0.96 ADRB2 (0.42) ADRB2ADRB1ADRB3L3MBTL1MAPT
SCHEMBL963633 0.96 ADRB2 (0.42) ADRB2ADRB1ADRB3L3MBTL1MAPT
SCHEMBL3990604 0.92 ADRB2 (0.42) ADRB2ADRB1ADRB3DRD2DRD1
SCHEMBL959403 0.92 ADRB2 (0.42) ADRB2ADRB1ADRB3DRD2DRD1
SCHEMBL5763148 0.89 ADRB2 (0.42) ADRB2ADRB1DRD2DRD1DRD4
SCHEMBL5763122 0.89 ADRB2 (0.42) ADRB2ADRB1DRD2DRD1DRD4
SCHEMBL17633021 0.89 ADRB2 (0.42) ADRB2ADRB1DRD2DRD1DRD4
SCHEMBL28423949 0.88 ADRB2 (0.42) ADRB2ADRB1ADRB3MAPTDRD2
SCHEMBL28423946 0.88 ADRB2 (0.42) ADRB2ADRB1ADRB3MAPTDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1615881-A2 DIARYLMETHYL AND RELATED COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY Theravance, Inc. (US) 2006-01-18 EP disclosed
WO-2004089892-A2 DIARYLMETHYL AND RELATED COMPOUNDS HAVING BETA2 ANDRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY THERAVANCE, INC. (US) 2004-10-21 WO disclosed